Αποτελέσματα Αναζήτησης
18 Οκτ 2021 · It is important to make a clinical decision about how to treat the person with diabetes. Regardless of any features of type 2 diabetes or absence of islet antibodies, if there is a clinical suspicion of type 1 diabetes, the individual should be treated with insulin.
While there are many adjunctive diabetes treatment options available today, there are few that have shown significant decreases in A1c in clinical trials. When evaluating these options, it is important to focus on the individual needs of the patient, discuss the risks and benefits of each treatment carefully and work together to come to a ...
4 Δεκ 2020 · If the A1C target is not achieved after approximately 3 months, metformin can be combined with any one of the preferred six treatment options: sulfonylurea, thiazolidinedione, DPP-4 inhibitor, SGLT2 inhibitor, GLP-1 RA, or basal insulin; the choice of which agent to add is based on drug-specific effects and patient factors (Fig. 9.1 and Table 9.1).
4 Δεκ 2020 · Measurement approximately every 3 months determines whether patients' glycemic targets have been reached and maintained. The frequency of A1C testing should depend on the clinical situation, the treatment regimen, and the clinician's judgment.
Type 1 diabetes mellitus is a metabolic disorder characterised by hyperglycaemia due to absolute insulin deficiency. Patients most often present with a few days or weeks of polyuria, polydipsia, weight loss, and weakness. Some patients may present with diabetic ketoacidosis.
The writing group has considered the rapid development of new treatments and technologies and addressed the following topics: diagnosis, aims of management, schedule of care, diabetes self-management education and support, glucose monitoring, insulin therapy, hypoglycaemia, behavioural considerations, psychosocial care, diabetic ketoacidosis ...
30 Σεπ 2021 · The writing group has considered the rapid development of new treatments and technologies and addressed the following topics: diagnosis, aims of management, schedule of care, diabetes self-management education and support, glucose monitoring, insulin therapy, hypoglycaemia, behavioural considerations, psychosocial care, diabetic ketoacidosis, pa...
